Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Disruptive Psychopharmacology -

Disruptive Psychopharmacology

Buch | Hardcover
VIII, 332 Seiten
2022 | 1st ed. 2022
Springer International Publishing (Verlag)
978-3-031-12183-8 (ISBN)
CHF 299,55 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.

Dosing psychedelics and MDMA.- Psychedelic Group Therapy.- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies.- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults.- Foundations for Training Psychedelic Therapists.- Ayahuasca for the Treatment of Depression.- Psilocybin for the Treatment of Depression.- Ketamine for the Treatment of Depression.- The Potential of Psychedelics for End of Life and Palliative Care.- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action.- Psilocybin for Tobacco Use Disorder.- Psychedelic Drugs as Anti-Inflammatory Agents.- Psilocybin for the Treatment of Obsessive-Compulsive Disorder.- Psilocybin for the Treatment of Headache and Pain Disorders.- Psilocybin for the Treatment of Neurodegenerative Disorders.- Psilocybin for Trauma-Related Disorders.

Erscheinungsdatum
Reihe/Serie Current Topics in Behavioral Neurosciences
Zusatzinfo VIII, 332 p. 100 illus., 30 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 619 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
Schlagworte addiction • dementia • entactogen • Hallucinogen • Headache • inflammation • LSD • MDMA • Microdosing • Mood Disorders • Neurodevelopmental Disorders • OCD • Pain • Palliative Care • Psilocybin • Psychedelic • PTSD • Substance use disorders
ISBN-10 3-031-12183-X / 303112183X
ISBN-13 978-3-031-12183-8 / 9783031121838
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75